Levels of GRP78 are elevated in a variety of tumors, including prostate, lung, breast, colon and gastric tumors, myeloma and leukemias and GRP78 expression is inversely correlated with cancer patient survival [22, 23, 27]. This evidence concerns the gene HSPA5 and plasma cell myeloma.